Pill mill fraud

What it is

A pill mill is a pain clinic or doctor’s office that exists to write prescriptions for opioids and other controlled substances to people who do not need them, rather than to treat pain. It shows up in two overlapping forms in the cases documented here. In the purest version, the clinic is a storefront: patients, often recruited by a crew leader and including people with no plausible pain complaint at all, pay cash for a prescription priced by the drug and its strength, and a captured or indifferent pharmacy fills it. In the other, the opioid prescription is paired with a medically unnecessary office visit or injection, and it is that visit, not the prescription, that gets billed to Medicare or Medicaid, turning the same underlying fraud into a claim against a federal health program rather than, or in addition to, a cash transaction.

Both versions share the same design flaw they exploit: a prescription written by a licensed doctor, on its face, looks exactly like legitimate medical care, right up until the volume, the pricing or the patient population gives it away.

How it actually works

1. A clinic that exists to prescribe, not to treat

   The office looks like a pain clinic; sometimes it is run day to day by a non-medical owner who hires a doctor to be the face and the signature on the prescription pad. Dr. Maryam Qayum’s Recare Health Clinic in Kingwood, Texas, and Dr. Oscar Lightner’s Jomori Health and Wellness in Houston both operated this way, built around one prescriber.

2. Patients who aren’t exactly patients

   Crew leaders bring in people with no real pain condition, sometimes recruited from homeless shelters, to pose as patients and obtain prescriptions for someone else to resell. At Recare, street-level drug dealers referred to in court documents as “providers” bought the prescriptions outright.

3. An exam that isn’t one

   Qayum, according to court documents, issued prescriptions “often without ever interacting with the patient” at all. There is no independent physical exam, no review of outside medical records, nothing that would surface in a real pain evaluation.

4. A price list, not a prescription

   Recare charged as much as $500 for an oxycodone 30mg prescription and $300 for hydrocodone, with staff taking cash “tips” from drug dealers to fast-track their prescriptions; Jomori charged $250 to $500 per visit. The price tracks the drug’s street value, not any cost of care.

5. The combination chosen for resale value, not medical need

   Lightner prescribed hydrocodone, carisoprodol (a muscle relaxant) and alprazolam (a benzodiazepine) together, a combination with real sedative and street-resale value and no legitimate reason to prescribe as a set.

6. A database nobody has to check

   Where it could have stopped

   Every state runs a Prescription Drug Monitoring Program (PDMP), an electronic database logging every controlled-substance prescription filled. The CDC says a PDMP is “only useful to healthcare providers if they check the system before prescribing,” and only some states require that check. A clinic distributing hundreds of thousands or millions of pills is visible in that data from its first prescription; what’s missing, until an investigation starts, is anyone required to look.

7. Some clinics add a second layer: billing the visit, not just the drug

   In Michigan, Dr. Francisco Patino pioneered what prosecutors called a “shots-for-pills” protocol: patients received an unnecessary back injection, billed to Medicare and Medicaid, and the opioid prescription was withheld if they refused it. The injection, not the pill, is what generated the fraudulent claim, over $250 million of them across the wider scheme, with more than $120 million attributed to Patino alone.

8. Enforcement, built from the prescribing data itself

   DEA diversion investigators, the Justice Department’s Health Care Fraud Section and, where billing is involved, HHS-OIG, build cases from exactly the data a PDMP would have surfaced earlier: outlier prescribing volume, a known pattern of drug combinations, and, in the billing variant, claims data showing a provider billing more of one procedure than anyone else in the state. In the cases documented here, that process took one to several years to reach an indictment.

Why it works

A prescription is, on its face, legitimate medical care. Unlike a street sale, it is signed by a licensed doctor and filled at a real pharmacy, which is exactly why a drug dealer would pay cash for one rather than simply selling pills already in hand.

The regulatory tool that would catch it only works if someone uses it. A Prescription Drug Monitoring Program logs every controlled-substance prescription in a state, but the CDC’s own description says it is useful only if a provider checks it, and checking is mandatory only in some states for some prescriptions. A pill mill’s outlier volume sits in that database the entire time it operates.

Cash payment hides in plain sight. A cash-only medical practice is not illegal on its own, and plenty of legitimate doctors run one; that same ordinary cover is what let Jomori collect $1.2 million in cash over just 14 months without a bank flagging a single transaction as suspicious.

The billing variant hides inside a real insurance claim. When a clinic pairs the prescription with a billed injection or office visit, the fraud against Medicare or Medicaid looks, in the claims system, exactly like a legitimate procedure, the same gap exploited on this site’s hospice-fraud and medicare-health-insurance pages.

The patient population is, by design, unlikely to complain. People buying a prescription to resell, or recruited from a shelter to pose as a patient, have no incentive to report a clinic that is giving them exactly what they came for.

Where it comes from

Entirely domestic in the cases documented here: a pill mill exploits the US system of licensed prescribers, state-run Prescription Drug Monitoring Programs and federal health insurance billing, a structure that does not exist in this form outside the United States.

South Florida’s pain-clinic boom around 2007 to 2010 gave the term its modern meaning, and Texas and Michigan produced the largest documented schemes here. The pain-clinic network behind Patino’s “shots for pills” scheme operated from 2007 to 2018, with 21 other defendants eventually sentenced alongside him.

The cash-only storefront and the insurance-billing scheme are different scales of the same fraud. Jomori and Recare each centered on a single prescriber and a handful of staff. Patino’s network layered opioid prescribing on top of a much larger billing-fraud operation, reaching more than $250 million in false claims across a conspiracy the Justice Department’s Health Care Fraud Section, which runs a dedicated Strike Force Model across nine federal districts, spent years building from prescribing and billing data.

National opioid dispensing has fallen for years, but unevenly. CDC data show the national dispensing rate dropping from 46.8 to 35.4 prescriptions per 100 people between 2019 and 2024, with Southern states including Arkansas and Alabama still dispensing roughly three times the rate of the lowest states, Hawaii and California, a gap that tracks where pill-mill prosecutions have concentrated.

Real cases

Red flags

• A cash-only clinic with a price list that scales by drug and milligram strength, rather than by the service provided.
• Little or no physical exam, and no request for prior medical records or imaging.
• The same combination of an opioid, a benzodiazepine and a muscle relaxant prescribed to most or all patients regardless of their stated complaint.
• Patients who travel long distances or arrive in groups, sometimes brought by the same driver or “crew leader.”
• Staff who accept tips or expedite fees to move a prescription through faster.
• A prescriber billing far more of one procedure or drug than any comparable provider in the state.
• A clinic that reopens under a new name shortly after losing a doctor’s license or a billing privilege.

If it’s happening to you

If you suspect a clinic near you is operating as a pill mill:

1. Don’t confront the clinic directly; report it instead. Contact the DEA’s tip line at 877-792-2873 or its online diversion complaint form.
2. If Medicare or Medicaid billing may be involved, report it to the HHS Office of Inspector General at 1-800-HHS-TIPS (1-800-447-8477) or TIPS.HHS.GOV, or to the Justice Department’s Health Care Fraud Section at [email protected].
3. See where to report for agencies in other countries.

If someone you know is being supplied by one:

1. A conversation about treatment is more useful than a confrontation. People buying from a pill mill are very often already struggling with addiction, not simply looking for cheap pills.
2. SAMHSA’s National Helpline, 1-800-662-4357, is free, confidential and available 24 hours a day, and can refer to local treatment options.
3. If a clinic suddenly closes or a prescriber loses their license, patients genuinely dependent on treatment can be left without care; a primary care provider or a local Federal Qualified Health Center (findahealthcenter.hrsa.gov) is the safer route to continued care than seeking out another pill mill.

Where the money goes

Mostly domestic and mostly cash at the point of collection, which is what makes it hard to trace until an investigation is already looking at the clinic specifically.

In the cash-only version, money moves directly from the patient or the street-level dealer to the clinic’s front desk, in cash, the same ordinary cover any legitimate cash-pay medical practice has. From there it moves into the operator’s own accounts, property and spending, exactly the kind of cash-intensive business flow investigators have to reconstruct after the fact rather than trace in real time. In the billing variant, Medicare or Medicaid pays the clinic directly into a bank account for the billed procedure, a payment that, unlike the cash collected at the front desk, leaves a federal paper trail from the moment it is paid, which is why prosecutors were able to attribute $120 million of the Patino scheme’s false billings to him individually, a figure traced directly from the claims data rather than estimated.

By the numbers

No published dataset breaks this scheme out as its own category yet, so there is no chart to show. The data page explains which agency categories exist and why some schemes are invisible in official statistics.